.png){kind=icon}
.png){kind=icon}
Return
Biliary Abnormality on Imaging During Lenvatinib Plus Hepatic Arterial Infusion Chemotherapy With Cisplatin for Hepatocellular Carcinoma: A Pilot Descriptive Study
.png){kind=icon}
OA
AI
H
K
T
N
T
K
A
A
S
T
S
DOI：10.1111/hepr.70228.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
To evaluate the frequency, imaging characteristics, associated factors, and clinical significance of biliary abnormalities on imaging in patients receiving lenvatinib (LEN) plus cisplatin hepatic arterial infusion chemotherapy (HAIC) for hepatocellular carcinoma (HCC).
Keywords:
biliary abnormality
cholangitis
cholecystitis
hepatic arterial infusion chemotherapy
hepatocellular carcinoma
lenvatinib
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.4
Papers:
4.2K
Citations:
4.9K
Organization
Cited Papers